Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Partial Onset Seizures
Interventions
DRUG

Investigational new drug, company code: BGG492

DRUG

Placebo

DRUG

Investigational new drug, company code: BGG492

Trial Locations (51)

112

Novartis Investigative Site, Taipei

1096

Novartis Investigative Site, Budapest

1113

Novartis Investigative Site, Sofia

3010

Novartis Investigative Site, Bern

5001

Novartis Investigative Site, Aarau

6000

Novartis Investigative Site, Kecskemét

8008

Novartis Investigative Site, Zurich

9700

Novartis Investigative Site, Szombathely

10016

NYU Comprehensive Epilepsy Center, New York

16321

Novartis Investigative Site, Bernau

19107

Thomas Jefferson University, Dept. of Psychiatry & Neurology, Philadelphia

20142

Novartis Investigative Site, Milan

21287

Johns Hopkins Hospital, Baltimore

30122

Novartis Investigative Site, Venezia

32308

AMO Corporation, Tallahassee

33305

Novartis Investigative Site, Lin-ko

33617

Novartis Investigative Site, Bielefeld

39564

Investigative Site - Private Practice, Ocean Springs

40123

Novartis Investigative Site, Bologna

Novartis Investigative Site, Milan

50143

Novartis Investigative Site, Florence

53127

Novartis Investigative Site, Bonn

65804

St.John's Research Institute, Inc, Springfield

72076

Novartis Investigative Site, Tübingen

72205

Clinical Trials, Inc., Little Rock

75230

Neurological Clinic of Texas, Dallas

77694

Novartis Investigative Site, Kehl-Kork

80131

Novartis Investigative Site, Napoli

80538

Medical Center of the Rockies, Loveland

85013

Barrow Neurological Clinics at St. Joseph's Hospital and MC, Phoenix

85718

Center for Neurosciences, Tucson

88100

Novartis Investigative Site, Catanzaro

89521

Renown Institute for Neurosciences, Reno

08873

NJ to Capital Health in Hamilton, Somerset

Princeton and Rutgers Neurology, Somerset

Unknown

Novartis Investigative Site, Marburg

Novartis Investigative SIte, Regensburg

Novartis Investigative Site, Ulm

Novartis Investigative Site, Bratislava

Novartis Investigative Site, Changhua

Novartis Investigative Site, Kaohsiung City

Novartis Investigative Site, Taipei

80-303

Novartis Investigative Site, Gdansk

31-209

Novartis Investigative Site, Krakow

02-957

Novartis Investigative Site, Warsaw

975 17

Novartis Investigative Site, Banská Bystrica

041 90

Novartis Investigative Site, Košice

110-744

Novartis Investigative Site, Seoul

120-752

Novartis Investigative Site, Seoul

135-710

Novartis Investigative Site, Seoul

738-736

Novartis Investigative Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY